share_log

中國中藥：根據《收購守則》規則22作出的交易披露

TRAD CHI MED: Disclosure of Dealings under Rule 22 of the Takeovers Code

香港交易所 ·  Mar 19 04:32
Summary by Moomoo AI
2024年3月18日，中国中药控股有限公司（簡稱中国中药）透過協議安排進行了股份私有化交易。根據香港《公司收購及合併守則》規則22，執行人員披露了相關的證券交易信息。在此次交易中，汪文汉以每股4.33港元的價格賣出了其持有的20,000股中国中药股份，交易後其持股比例為100%。汪文汉根據《公司收購及合併守則》的一致行動定義，被認定為與受要約公司有關連的人士。
2024年3月18日，中国中药控股有限公司（簡稱中国中药）透過協議安排進行了股份私有化交易。根據香港《公司收購及合併守則》規則22，執行人員披露了相關的證券交易信息。在此次交易中，汪文汉以每股4.33港元的價格賣出了其持有的20,000股中国中药股份，交易後其持股比例為100%。汪文汉根據《公司收購及合併守則》的一致行動定義，被認定為與受要約公司有關連的人士。
ON MARCH 18, 2024, CHINA PHARMACEUTICAL HOLDINGS LIMITED (CHINESE PHARMACEUTICALS) ENTERED INTO A SHARE PRIVATIZATION TRANSACTION THROUGH AN AGREED ARRANGEMENT. Pursuant to Rule 22 of the Hong Kong Code of Companies, the Executives disclose relevant securities transaction information. In this transaction, Wang Wenhan sold 20,000 shares of Chinese pharmaceutical stocks held at HK$4.33 per share, with a holding ratio of 100% after the transaction. WANG WENHAN IS CONSIDERED TO BE A PERSON ASSOCIATED WITH A CONTRACTED COMPANY UNDER THE UNIFORM CODE OF CONDUCT DEFINED IN THE CODE OF ACQUISITIONS AND MERGERS.
ON MARCH 18, 2024, CHINA PHARMACEUTICAL HOLDINGS LIMITED (CHINESE PHARMACEUTICALS) ENTERED INTO A SHARE PRIVATIZATION TRANSACTION THROUGH AN AGREED ARRANGEMENT. Pursuant to Rule 22 of the Hong Kong Code of Companies, the Executives disclose relevant securities transaction information. In this transaction, Wang Wenhan sold 20,000 shares of Chinese pharmaceutical stocks held at HK$4.33 per share, with a holding ratio of 100% after the transaction. WANG WENHAN IS CONSIDERED TO BE A PERSON ASSOCIATED WITH A CONTRACTED COMPANY UNDER THE UNIFORM CODE OF CONDUCT DEFINED IN THE CODE OF ACQUISITIONS AND MERGERS.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more